Invention Grant
- Patent Title: Crystalline anti-hTNFalpha antibodies
- Patent Title (中): 结晶抗hTNFalpha抗体
-
Application No.: US13774706Application Date: 2013-02-22
-
Publication No.: US08772458B2Publication Date: 2014-07-08
- Inventor: Anette Koenigsdorfer , Stefan Gottschalk , Hans-Juergen Krause , Gerhard Winter , David W. Borhani , Wolfgang Fraunhofer
- Applicant: AbbVie Biotechnology Ltd
- Applicant Address: BM Hamilton
- Assignee: AbbVie Biotechnology Ltd
- Current Assignee: AbbVie Biotechnology Ltd
- Current Assignee Address: BM Hamilton
- Agency: McCarter & English, LLP
- Agent Cristin H. Cowles; Soo-Hwa Kim
- Main IPC: C07K16/00
- IPC: C07K16/00
Abstract:
The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.
Public/Granted literature
- US20130309309A1 CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES Public/Granted day:2013-11-21
Information query
